Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about what causes Parkinson’s disease and what can be done to reduce the ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Environmental factors like prolonged stress, chronic inflammation and toxic exposure could play a key role in triggering ...

A drug trial underway at Macquarie University is taking advantage of an early warning sign of Parkinson's in the hope of ...

Parkinson’s disease causes tremors, rigidity, and a loss of mobility over time, eventually leaving patients disabled. This ...

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

Of course, with such a complicated chain of events involved in Parkinson's disease, not all patients likely experience the ...

Scientists at La Trobe University have created a world-first method to investigate 'disordered' proteins in living cells, in ...